PHT-1
PT
Menu
Search

Sections

  • Home
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Sectors
    • Clinical Trials
    • Drug Manufacturers
    • Therapy Area
      • Cardiovascular
      • Central Nervous System
      • Immunology
      • Infectious Disease
      • Oncology
      • Respiratory
  • Themes
    • Artificial Intelligence
    • Corporate Governance
    • Cloud
    • Cybersecurity
    • Environmental Sustainability
    • Internet of Things
    • Robotics
    • Social Responsibility
    • Covid-19
  • Insights
    • Deals
    • Jobs
    • Filings
    • Patents
    • Social Media
  • Companies
    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos
    • Buyer’s Guides
    • Partner Content
  • Pricing and Market Access
  • Events
  • Reports
  • Premium Insights
  • Excellence Awards
  • Magazine

GlobalData

  • About us
  • Advertise With Us
  • Contact Us
  • Our Marketing Solutions
  • GlobalData Reports
  • Visit GlobalData

From Our Partners

  • Transforming MedTech and Pharma using Software as a Medical Device (SaMD)
  • Accelerating Biopharmaceutical Innovation
  • Accelerating Clinical Trials
  • Precision medicine and digital health innovation for disease diagnosis, care and treatment
  • Enabling process intensification in biopharma manufacturing
  • Specialty drug launch strategy and operations
  • The next chapter of clinical trial services
  • Future Pharma Services
  • Putting quality first in the pharma supply chain
  • Enabling better biopharmaceutical manufacturing
  • Pharmaceutical Grade Silicone Manufacturer
  • Maximising molecule potential
  • News
  • Analysis

    Sections

    • Features
    • Comment
    • Projects

    Latest

    • Magazine: The journey of first generics
    • Cybersecurity in pharma: Securing the future
    • ASCO 2023: Keytruda becomes a new option in perioperative NSCLC  
  • Sectors

    Sections

    • Clinical Trials
    • Drug Manufacturers
    • Therapy Area

    Latest

    • ASCO 2023: Ellipses Pharma advances plans for RET inhibitor following encouraging results
    • ASCO 2023: Moderna and MSD’s vaccine/IO combo reduces chances of melanoma spreading
    • Oragenics secures CQDM funding for Covid-19 vaccine antigen development
  • Themes

    Sections

    • Artificial Intelligence
    • Cloud
    • Corporate Governance
    • Cybersecurity
    • Environmental Sustainability
    • Internet of Things
    • Robotics
    • Social Responsibility
    • Covid-19

    Latest

    • Cybersecurity in pharma: Securing the future
    • XtalPi announces $250m AI drug discovery collaboration with Eli Lilly
    • University of Sydney will use AI to boost cancer drug research
  • Insights

    Sections

    • Deals
    • Jobs
    • Filings
    • Patents
    • Social Media

    Latest

    • Who’s investing where? Private equity deal activity in the pharmaceutical industry in Europe decreased by 29% in Q1 2023
    • Who’s acquiring who? M&A activity in the pharmaceutical industry in Japan decreased by 5% in Q1 2023
    • Who’s investing where? Private equity deal activity in the pharmaceutical industry in The US decreased by 27% in Q1 2023
  • Companies

    Sections

    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos
    • Buyer’s Guides
    • Partner Content

    Latest

    • The European Reference Genome Atlas Initiative: Advancing understanding of European biodiversity
    • Communications in life sciences: Uncovering the Unlocked survey results
    • Medicines adherence: Overcoming pharma’s biggest barrier to treatment success
  • Events
  • Reports
  • Premium Insights
PT
February 28, 2022

2nd Mitochondria-Targeted Drug Development Summit

By IndiaProduction

IndiaProduction

Share this article

Recommended Reports

  • ReportsLogo
    Reports

    Neurofibromatoses Type II Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

    GlobalData
  • ReportsLogo
    Reports

    Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) Drugs in Development by Therapy Areas and...

    GlobalData
View all

Companies Intelligence

Omicron Holding GmbH

Fujifilm Holdings Corp

View all

IndiaProduction

PharmaceuticalTechnology

The leading site for news and procurement in the pharmaceutical industry

  • About us
  • Advertise with us
  • License our content
  • Contact us
  • Editorial approach
  • Newsletters
  • Our marketing solutions
  • Privacy policy
  • Terms and conditions

Powered by Pharma Tech Logo

© Verdict Media Limited 2023

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.